Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages
Ying Sun, Huitong Yang, Xue Mei, Jinchan Xia, Long Feng, Jianfeng Gao, Wei Jiang, Min Jiang, Xu Hao, Yilin Feng, Yunfeng Lian Medical College, Henan University of Chinese Medicine, Zhengzhou, Henan, 450046, People’s Republic of ChinaCorrespondence: Ying Sun, Medical College, Henan University of Chin...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-08-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/cinobufagin-inhibits-invasion-and-migration-of-non-small-cell-lung-can-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849698292440498176 |
|---|---|
| author | Sun Y Yang H Mei X Xia J Feng L Gao J Jiang W Jiang M Hao X Feng Y Lian Y |
| author_facet | Sun Y Yang H Mei X Xia J Feng L Gao J Jiang W Jiang M Hao X Feng Y Lian Y |
| author_sort | Sun Y |
| collection | DOAJ |
| description | Ying Sun, Huitong Yang, Xue Mei, Jinchan Xia, Long Feng, Jianfeng Gao, Wei Jiang, Min Jiang, Xu Hao, Yilin Feng, Yunfeng Lian Medical College, Henan University of Chinese Medicine, Zhengzhou, Henan, 450046, People’s Republic of ChinaCorrespondence: Ying Sun, Medical College, Henan University of Chinese Medicine, Zhengzhou, Henan, 450046, People’s Republic of China, Email sunying0109@163.comBackground: The immunosuppressive tumor microenvironment (TME) in lung cancer, driven in part by M2-polarized tumor-associated macrophages (TAMs), contributes to worse prognosis and supports tumor progression. Cinobufagin (CB), an active compound in cinobufotalin injections, has demonstrated potential antitumor effects by modulating macrophage activity. This study investigated the mechanism by which CB influences glucose metabolism and polarization in M2 TAMs by focusing on the regulation of HIF-1α.Methods: Human THP-1 monocytes were differentiated into M2 macrophages by stimulation with interleukin-4 at 20 ng/mL and then treated with cinobufagin at 2 μM, either alone or together with the HIF-1α activator DMOG at 1 mM. HIF-1α hydroxylation and ubiquitination were evaluated by Western blot and co-immunoprecipitation. Glycolytic activity was determined by measuring uptake of the glucose analogue 2-NBDG, extracellular lactate levels and expression of GLUT1, PKM2, LDHA and MCT1. M2 polarization markers CD206, Arg-1 and IL-10 were quantified by qRT-PCR, and TGF-β and IL-10 secretion was measured by ELISA. PD-L1 expression was assessed by Western blot, immunofluorescence and chromatin immunoprecipitation. Finally, conditioned media from treated macrophages were applied to A549 cells to evaluate migration through wound-healing assays and invasion using Transwell inserts, and to HUVECs to quantify tube formation.Results: Using DMOG, an HIF-1α activator, we stimulated glycolysis in M2 macrophages, promoting their immunosuppressive polarization and elevating PD-L1 expression, a checkpoint protein associated with immune evasion. CB treatment reversed this effect by increasing HIF-1α hydroxylation and ubiquitination, leading to decreased HIF-1α stability, glucose uptake, and lactate production in M2 macrophages. Additionally, CB pre-treatment of M2 macrophages reduced the secretion of the cytokines TGF-β and IL-10, thereby limiting lung cancer cell migration, invasion, and angiogenesis.Conclusion: These findings suggest that CB suppresses M2 macrophage-mediated tumor support by targeting HIF-1α and glycolysis, thereby reprogramming the TME toward an anti-tumor state. This highlights CB’s potential of CB in the treatment of lung cancer by countering immunosuppressive macrophage activity.Keywords: TAMs, metabolic reprogramming, TME, cancer immunotherapy, lung cancer |
| format | Article |
| id | doaj-art-e6c2e3625e144cfbb04c23deb372eeaa |
| institution | DOAJ |
| issn | 1177-8881 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj-art-e6c2e3625e144cfbb04c23deb372eeaa2025-08-20T03:18:56ZengDove Medical PressDrug Design, Development and Therapy1177-88812025-08-01Volume 19Issue 166476664105397Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated MacrophagesSun Y0Yang HMei X1Xia JFeng L2Gao JJiang WJiang M3Hao XFeng YLian YMedical CollegeSchool of MedicineMicrobiology and immunologySchool of MedicineYing Sun, Huitong Yang, Xue Mei, Jinchan Xia, Long Feng, Jianfeng Gao, Wei Jiang, Min Jiang, Xu Hao, Yilin Feng, Yunfeng Lian Medical College, Henan University of Chinese Medicine, Zhengzhou, Henan, 450046, People’s Republic of ChinaCorrespondence: Ying Sun, Medical College, Henan University of Chinese Medicine, Zhengzhou, Henan, 450046, People’s Republic of China, Email sunying0109@163.comBackground: The immunosuppressive tumor microenvironment (TME) in lung cancer, driven in part by M2-polarized tumor-associated macrophages (TAMs), contributes to worse prognosis and supports tumor progression. Cinobufagin (CB), an active compound in cinobufotalin injections, has demonstrated potential antitumor effects by modulating macrophage activity. This study investigated the mechanism by which CB influences glucose metabolism and polarization in M2 TAMs by focusing on the regulation of HIF-1α.Methods: Human THP-1 monocytes were differentiated into M2 macrophages by stimulation with interleukin-4 at 20 ng/mL and then treated with cinobufagin at 2 μM, either alone or together with the HIF-1α activator DMOG at 1 mM. HIF-1α hydroxylation and ubiquitination were evaluated by Western blot and co-immunoprecipitation. Glycolytic activity was determined by measuring uptake of the glucose analogue 2-NBDG, extracellular lactate levels and expression of GLUT1, PKM2, LDHA and MCT1. M2 polarization markers CD206, Arg-1 and IL-10 were quantified by qRT-PCR, and TGF-β and IL-10 secretion was measured by ELISA. PD-L1 expression was assessed by Western blot, immunofluorescence and chromatin immunoprecipitation. Finally, conditioned media from treated macrophages were applied to A549 cells to evaluate migration through wound-healing assays and invasion using Transwell inserts, and to HUVECs to quantify tube formation.Results: Using DMOG, an HIF-1α activator, we stimulated glycolysis in M2 macrophages, promoting their immunosuppressive polarization and elevating PD-L1 expression, a checkpoint protein associated with immune evasion. CB treatment reversed this effect by increasing HIF-1α hydroxylation and ubiquitination, leading to decreased HIF-1α stability, glucose uptake, and lactate production in M2 macrophages. Additionally, CB pre-treatment of M2 macrophages reduced the secretion of the cytokines TGF-β and IL-10, thereby limiting lung cancer cell migration, invasion, and angiogenesis.Conclusion: These findings suggest that CB suppresses M2 macrophage-mediated tumor support by targeting HIF-1α and glycolysis, thereby reprogramming the TME toward an anti-tumor state. This highlights CB’s potential of CB in the treatment of lung cancer by countering immunosuppressive macrophage activity.Keywords: TAMs, metabolic reprogramming, TME, cancer immunotherapy, lung cancerhttps://www.dovepress.com/cinobufagin-inhibits-invasion-and-migration-of-non-small-cell-lung-can-peer-reviewed-fulltext-article-DDDTTAMsmetabolic reprogrammingTMEcancer immunotherapylung cancer |
| spellingShingle | Sun Y Yang H Mei X Xia J Feng L Gao J Jiang W Jiang M Hao X Feng Y Lian Y Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages Drug Design, Development and Therapy TAMs metabolic reprogramming TME cancer immunotherapy lung cancer |
| title | Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages |
| title_full | Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages |
| title_fullStr | Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages |
| title_full_unstemmed | Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages |
| title_short | Cinobufagin Inhibits Invasion and Migration of Non-Small Cell Lung Cancer via Regulating Glucose Metabolism Reprogramming in Tumor-Associated Macrophages |
| title_sort | cinobufagin inhibits invasion and migration of non small cell lung cancer via regulating glucose metabolism reprogramming in tumor associated macrophages |
| topic | TAMs metabolic reprogramming TME cancer immunotherapy lung cancer |
| url | https://www.dovepress.com/cinobufagin-inhibits-invasion-and-migration-of-non-small-cell-lung-can-peer-reviewed-fulltext-article-DDDT |
| work_keys_str_mv | AT suny cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT yangh cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT meix cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT xiaj cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT fengl cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT gaoj cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT jiangw cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT jiangm cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT haox cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT fengy cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages AT liany cinobufagininhibitsinvasionandmigrationofnonsmallcelllungcancerviaregulatingglucosemetabolismreprogrammingintumorassociatedmacrophages |